Medisafe launches new program, Mediscoveries, providing unique insight into medication management performance
Orlando, FL, February 12, 2019. Medisafe, the leading medication management platform with over five and a half million registered users, announced today a new program providing insights into medicine management behaviors and drug efficacy called Mediscoveries.
For over six years Medisafe has amassed proprietary data on medication adherence on over two billion successful medication doses. This self-reported aggregated data provides exclusive insight into consumer behaviors such as actual dosing schedules, reasons for skipping, switching patterns and overall adherence and persistence patterns to impact:
- Consumption patterns
- Needed treatment interventions
- Competitive benchmarking
“Medisafe is uniquely positioned to provide consumer driven insights into medication adherence and its impact,” says Omri Shor, CEO and Founder of Medisafe. “Our Mediscoveries program deep dives into the data to link real-time actual consumer medication consumption and overall medication management implications. 50% of medications are typically not taken as prescribed, so delivering this information to the healthcare eco-system is critical for managing cost, quality and medication effectiveness.”
In the coming months, Medisafe will continue to share Mediscoveries across therapeutic areas.
The Medisafe team will be available at HIMSS 2019 at booth #4224 to share our ground breaking Mediscoveries around an Asthma brand. To schedule a meeting please click here.
Jennifer Butler, Chief Marketing Officer